Phathom Pharmaceuticals, Inc. PHAT Inventory write-downs
Inventory write-downs at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryWriteDown.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s inventory write-downs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s inventory write-downs?
- Phathom Pharmaceuticals, Inc. (PHAT) reported inventory write-downs of $0 in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s inventory write-downs changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s inventory write-downs decreased by 100.0% year-over-year, from $899K to $0.
- What does inventory write-downs mean?
- This represents the reduction in the carrying value of inventory due to obsolescence, spoilage, or market value decline below cost. For a biopharmaceutical company, this often signals potential issues with product shelf life or commercial viability. It serves as a key indicator of supply chain efficiency and inventory management health.